ArticleBioactive materials2026
Pre-priming cell sheet therapy enabled by dynamic wrinkled electroactive substrate for muscle reconstruction.
Article in Bioactive materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Current therapeutic approaches for muscle reconstruction face considerable challenges, particularly in generating sufficiently dense cell aggregates and in establishing effective methods for reactivating the function of exogenous cells. Herein, we developed a pre-priming cell sheet therapy for volumetric muscle loss (VML) that leverages highly dense, electro-mechanically bioactive constructs. To achieve this goal, we fabricated a multifunctional cell culture platform based on a near-infrared (NIR)-responsive, wrinkle-patterned, conductive substrate. This system enables scalable preparation (>6 mm in diameter), non-invasive harvesting, and bioactive pre-priming of cell sheets for transplantation. Non-invasive harvesting of the sheets is achieved via a NIR-triggered release mechanism, in which dynamic changes in wrinkle morphology induce a sufficient shift in mechanical stress at the cell-substrate interface, thereby disrupting focal adhesions. Compared with conventional cell-suspension therapy, the microstructured electroactive surface demonstrated superior efficacy for VML repair, as evidenced by integrated in vitro electrophysiology, RNA sequencing, and
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.